Showing results (801-810 of 4,872) with videos related to

Sort By:
Pageof 488
Urologic Oncology|July 15, 2014
Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomyBoyd R Viers, Robert Houston Thompson, Stephen A Boorjian, et al.
Urologic Oncology|July 16, 2014
The effect of smoking and timing of smoking cessation on clinical outcome in non-muscle-invasive bladder cancerAnne J Grotenhuis, Cornelis W Ebben, Katja K Aben, et al.
Urologic Oncology|July 16, 2014
The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomyKyle A Richards, Joshua A Cohn, Michael C Large, et al.
Urologic Oncology|August 19, 2014
MALDI imaging-based identification of prognostically relevant signals in bladder cancer using large-scale tissue microarraysStefan Steurer, Julius Magnus Singer, Michael Rink, et al.
Urologic Oncology|August 19, 2014
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patientsGuillaume Ploussard, Hendrik Isbarn, Alberto Briganti, et al.
Urologic Oncology|September 7, 2014
Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinomaJiancheng Zhou, Zhuo Deng, Yule Chen, et al.
Urologic Oncology|September 21, 2014
Significance of perivesical lymph nodes in radical cystectomy for bladder cancerBrian Hu, Raj Satkunasivam, Anne Schuckman, et al.
Urologic Oncology|December 11, 2013
Essential elements of personalized medicineWylie Burke, Susan Brown Trinidad, Nancy A Press
Urologic Oncology|December 11, 2013
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS studyGoebell P J, Münch A, Müller L, et al.
Urologic Oncology|December 11, 2013
Clinical prognostic factors associated with outcome in patients with renal cell cancer with prior tyrosine kinase inhibitors or immunotherapy treated with everolimusRobert J Amato, Amber Flaherty, Yufeng Zhang, et al.
Pageof 488